# Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)

> **NCT01380535** · EARLY_PHASE1 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 60 (actual)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **DRUG:** ECP Methoxsalen
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT01380535
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380535, "Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01380535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*